[Speech disorders in children with cerebral convulsions].
D000293:Adolescent; D001463:Barbiturates / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004569:Electroencephalography; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy; D005013:Ethosuximide / Q000009:adverse effects; D006801:Humans; D008297:Male; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D013064:Speech Disorders / Q000175:diagnosis / Q000209:etiology*; D013070:Speech Therapy; D014705:Verbal Behavior
D001463:Barbiturates; D011324:Primidone; D002220:Carbamazepine; D005013:Ethosuximide; D010672:Phenytoin; D010634:Phenobarbital
Die Sprachstörungen bei Kindern mit cerebralen Krampfanfällen.